Conjugate Vaccines Market by Type and Geography - Forecast and Analysis 2020-2024

The global conjugate vaccines market size has the potential to grow by USD 7.27 billion during 2020-2024. The market’s growth momentum will accelerate throughout the forecast period because of the steady increase in year-over-year growth.

This report provides a detailed analysis of the market by type (multivalent conjugate vaccine and monovalent conjugate vaccine) and geography (Asia, Europe, North America, and ROW). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors, including Aurobindo Pharma Ltd., GlaxoSmithKline Plc, Integrated Biotherapeutics Inc., Merck & Co. Inc., Mitsubishi Tanabe Pharma Corp., Pfenex Inc., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., and Sun Pharmaceutical Industries Ltd.  

Market Overview

Browse TOC and LoE with selected illustrations and example pages of conjugate vaccines market

Request a FREE sample now!

Market Competitive Analysis

The conjugate vaccines market is currently moderately fragmented. The degree of fragmentation will increase slightly over the forecast period. With significant business growth scope in the market, vendors are focusing on R&D to release novel conjugate vaccines, which will increase their market penetration and revenue generation. Pfenex Inc., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., and Sun Pharmaceutical Industries Ltd. are a few of the significant market participants. Although the awareness about immunization programs, and access to vaccines will offer immense business opportunities to vendors, the high cost associated with vaccine research, development, and manufacturing will challenge the growth of many. To make the most of the possibilities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

To help clients improve their market positions, this conjugate vaccines market forecast report provides a detailed analysis of the market leaders and offers information on the competencies and capacities of the companies. The report also covers details on the market’s competitive landscape and provides information on the products offered by various companies. This conjugate vaccines market analysis report also includes information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of their future growth opportunities.

This report provides information on the production, sustainability, and prospects of several leading conjugate vaccines companies, including:

• Aurobindo Pharma Ltd.
• GlaxoSmithKline Plc
• Integrated Biotherapeutics, Inc.
• Merck & Co., Inc.
• Mitsubishi Tanabe Pharma Corp.
• Pfenex Inc.
• Pfizer Inc.
• Sanofi
• Serum Institute of India Pvt. Ltd.
• Sun Pharmaceutical Industries Ltd.   

Conjugate Vaccines Market: Segmentation by Region

For more insights on the conjugate vaccines market share of various regions Request for a FREE sample now!

North America accounted for the largest market share in 2019, and the region will continue to offer maximum growth opportunities to vendors over the forecast period. The prevalence of infectious diseases such as pneumococcal diseases, influenza, diphtheria, tetanus, pertussis, and meningococcal is fueling the demand for conjugate vaccines in North America. Moreover, the regional market is recording an increasing number of initiatives to raise awareness about immunization programs and improve access to vaccines.

Almost 48% of the overall market’s growth will originate from North America during the forecast period. The US and Canada are the key markets for conjugate vaccines in the region. The market growth rate in this region will be slower than that of Asia over the forecast period.

Conjugate Vaccines Market: Segmentation by Type

Request for a FREE sample and Get more information on the market contribution from various types of conjugate vaccines

Multivalent conjugate vaccines are widely used to prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive diseases. The US FDA has approved many multivalent conjugate vaccines, which is expected to increase sales. As a result, the conjugate vaccines market growth by the multivalent conjugate vaccines segment will be significant over the forecast period.

The growth rate of the multivalent conjugate vaccine segment is expected to be slower compared with the monovalent conjugate vaccine segment over the forecast period. This report provides an accurate prediction of the contribution of all the segments to the growth of the conjugate vaccines market size.

Conjugate Vaccines Market: Key Drivers and Trends

Typhoid, pneumonia, meningitis, tetanus, diphtheria, and pertussis can cause serious harm, especially to infants and children. The lack of awareness about immunization can lead to the continuation of these deadly diseases. Therefore, increasing awareness about immunization programs and access to vaccines have become essential. Organizations across the world are taking many initiatives to raise awareness about immunization programs. Immunization programs are well-recognized and successful public health programs worldwide. Also, there are initiatives aimed at increasing access to vaccines worldwide. For instance, the International Medical Humanitarian Organization rolled out a vaccination campaign named Humanitarian Mechanism in May 2017 to provide access to expensive pneumonia vaccines to refugee children on the Greek islands of Chios, Samos, and Lesvos. These factors are expected to increase sales of conjugate vaccines over the forecast period, contributing to the global conjugate vaccines market growth.

• The production process of conjugate vaccines is challenging and involves a laborious process with low yields.
• Conjugate vaccines are synthesized chemically and vary in each batch.
• To address the challenges associated with the production of conjugate vaccines, manufacturers have come up with chemical strategies such as bioconjugation that is one of the critical conjugate vaccines market trends.
• Bioconjugation uses oligosaccharyltransferase - which does not have the limitations associated with other conjugating enzymes.
• The market will grow at a CAGR of over 9% during 2020-2024.

Request for a FREE sample now!

Conjugate Vaccines Market: Key Highlights of the Report for the Forecast Period 2020-2024

• CAGR of the market during the forecast period 2020-2024
• Detailed information on factors that will accelerate the growth of the conjugate vaccines market during the next five years
• Precise estimation of the global conjugate vaccines market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the conjugate vaccines industry in Asia, Europe, North America, and ROW
• A thorough analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of conjugate vaccines vendors   

We can help! Our analysts can customize this report to meet your requirements. Get in touch